- Home
- APLS vs ROOT Comparison
APLS vs ROOT Comparison
Compare APLS & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ROOT
- Stock Information
- Founded
- APLS 2009
- ROOT 2015
- Country
- APLS United States
- ROOT United States
- Employees
- APLS N/A
- ROOT N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ROOT Property-Casualty Insurers
- Sector
- APLS Health Care
- ROOT Finance
- Exchange
- APLS Nasdaq
- ROOT Nasdaq
- Market Cap
- APLS 2.2B
- ROOT 2.3B
- IPO Year
- APLS 2017
- ROOT 2020
- Fundamental
- Price
- APLS $16.93
- ROOT $130.99
- Analyst Decision
- APLS Buy
- ROOT Buy
- Analyst Count
- APLS 19
- ROOT 7
- Target Price
- APLS $37.50
- ROOT $120.83
- AVG Volume (30 Days)
- APLS 2.9M
- ROOT 477.5K
- Earning Date
- APLS 05-07-2025
- ROOT 05-07-2025
- Dividend Yield
- APLS N/A
- ROOT N/A
- EPS Growth
- APLS N/A
- ROOT N/A
- EPS
- APLS N/A
- ROOT 3.16
- Revenue
- APLS $775,839,000.00
- ROOT $1,271,000,000.00
- Revenue This Year
- APLS $1.54
- ROOT $22.14
- Revenue Next Year
- APLS $22.80
- ROOT $10.44
- P/E Ratio
- APLS N/A
- ROOT $41.45
- Revenue Growth
- APLS 48.04
- ROOT 98.66
- 52 Week Low
- APLS $16.10
- ROOT $34.04
- 52 Week High
- APLS $43.76
- ROOT $181.14
- Technical
- Relative Strength Index (RSI)
- APLS 41.44
- ROOT 46.48
- Support Level
- APLS $16.61
- ROOT $123.65
- Resistance Level
- APLS $17.48
- ROOT $133.55
- Average True Range (ATR)
- APLS 0.86
- ROOT 7.56
- MACD
- APLS 0.09
- ROOT -1.46
- Stochastic Oscillator
- APLS 28.47
- ROOT 23.11
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.